🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Management of Traumatic Pancreas Transection

Recruitingn/aAges 1 Year - 70 YearsAllNational Cheng-Kung University Hospital
NCT05856474 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this observational study is to learn about the type of surgical effect on pancreas transection. The main questions aims to answer are: * 1\. does pancreas preserving able to decrease incidence of postoperative diabeters * 2\. what is cause of major cause of postoperative morbidity and mortality in pancreas transection

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Diagnosed to have pancreas injury confirmed to pancreas injury by laparotomy. Exclusion Criteria: * negative pancreas injury by laparotomy
💊

What it tests

  • pancreatectomy
📍

Where

1 site
National Cheng Kung University Hospital
Tainan, Taiwan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy